Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Clinical trial NCT06206512 · COMPLETED
Trial details
- NCT number
- NCT06206512
- Sponsor
- Sarfez Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-15
- Primary completion
- 2025-11-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.